We have advised MCH Private Equity, a leading Spanish investment firm, on its investment in Sanfil Medicina, a private healthcare group headquartered in Coimbra, Portugal.
Sanfil Medicina operates hospitals and clinics across the central region of Portugal, offering integrated healthcare services through its Sanfil Medicina (general hospitals), Diaton (diagnostics and imaging) and Nefrovida (dialysis) units. The group employs over 500 professionals, collaborates with hundreds of medical specialists, and is widely recognised for the quality of its clinical services and strong ties to local communities. In 2024, Sanfil generated revenues of approximately €67m and an EBITDA of €8m.
The investment by MCH Private Equity will support Sanfil Medicina’s growth plan, including the expansion of facilities, technological upgrades and potential external growth opportunities. This strategic partnership aims to consolidate Sanfil’s leadership in the private healthcare sector in Portugal, enhancing its capacity to deliver high-quality care and explore new avenues of development.
MCH Private Equity manages over €1.8bn in assets and has a strong track record of investments in innovation and technology, food and agribusiness, and health, wellness and lifestyle sectors. In Portugal, MCH controls Brasmar, Active Hearing (Audição Activa) and Logalty/DigitalSign.
